miRNA-205 Is a Candidate Tumor Suppressor that Targets ZEB2 in Renal Cell Carcinoma

Publisher： Karger

E-ISSN： 2296-5262|37|11|658-664

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.11, 2014-10, pp. : 658-664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miRNA profiles for the treatment of HCC

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 2, 2015-01 ,pp. : 128-141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Re‐expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 8, 2015-09 ,pp. : 578-584

John Wiley & Sons Inc

Access to resources Recommend Favorite

Screening of Alternative Drugs to the Tumor Suppressor miR-375 in Esophageal Squamous Cell Carcinoma Using the Connectivity Map

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 351-363

Karger

Access to resources Recommend Favorite

Altered levels of miR‐21, miR‐125b‐2*, miR‐138, miR‐155, miR‐184, and miR‐205 in oral squamous cell carcinoma and association with clinicopathological characteristics

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 10, 2015-11 ,pp. : 792-800

John Wiley & Sons Inc

Access to resources Recommend Favorite

Screening for miRNAs and their potential targets in response to TGF-β1 based on miRNA microarray and comparative proteomics analyses in a mouse GC-1 spg germ cell line

By  

International Journal of Molecular Medicine, Vol. 35, Iss. 3, 2015-01 ,pp. : 821-828

Spandidos Publications

Access to resources Recommend Favorite